The following figures show the history of Avastin (bevacizumab, anti-VEGF antibody)-related patents and biosimilar approval in Japan.

Figure 1:  Avastin (bevacizumab, anti-VEGF antibody)-related patents in Japan

PDF view
Figure 2:  Avastin (bevacizumab)-related patents and Re-examination period in Japan

PDF view
Figure 3:  Pfizer's Avastin biosimilar approved in Japan

PDF view
Sponsored link
Recommended articles